Daniel Mack - Net Worth and Insider Trading

Daniel Mack Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel Mack owns 4 companies in total, including ImageWare Systems Inc (IWSY) , GUE Liquidation Co Inc (FTDCQ) , and Viveve Medical Inc (VIVE) among others .

Click here to see the complete history of Daniel Mack’s form 4 insider trades.

Insider Ownership Summary of Daniel Mack

Ticker	Comapny	Transaction Date	Type of Owner
IWSY	ImageWare Systems Inc	2020-10-12	10 percent owner
FTDCQ	GUE Liquidation Co Inc	2019-06-13	10 percent owner
VIVE	Viveve Medical Inc	2019-04-25	10 percent owner
		2023-06-13	10 percent owner

Daniel Mack Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daniel Mack Ownership Network

Ownership Network List of Daniel Mack

No Data

Ownership Network Relation of Daniel Mack

Daniel Mack Owned Company Details

What does ImageWare Systems Inc do?

Who are the key executives at ImageWare Systems Inc?

Daniel Mack is the 10 percent owner of ImageWare Systems Inc. Other key executives at ImageWare Systems Inc include 10 percent owner Neal I Goldman , SVP and CFO Jay B Lewis , and 10 percent owner Nantahala Capital Partners Ii Limited Partnership .

ImageWare Systems Inc (IWSY) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of ImageWare Systems Inc (IWSY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ImageWare Systems Inc (IWSY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

ImageWare Systems Inc (IWSY)'s detailed insider trading history can be found in Insider Trading Tracker table.

ImageWare Systems Inc Insider Transactions

No Available Data

What does GUE Liquidation Co Inc do?

Who are the key executives at GUE Liquidation Co Inc?

Daniel Mack is the 10 percent owner of GUE Liquidation Co Inc. Other key executives at GUE Liquidation Co Inc include 10 percent owner Morris Lichtenstein , 10 percent owner Nantahala Capital Management, Llc , and 10 percent owner Wilmot B. Harkey .

GUE Liquidation Co Inc (FTDCQ) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of GUE Liquidation Co Inc (FTDCQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of GUE Liquidation Co Inc (FTDCQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

GUE Liquidation Co Inc (FTDCQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

GUE Liquidation Co Inc Insider Transactions

No Available Data

What does Viveve Medical Inc do?

Who are the key executives at Viveve Medical Inc?

Daniel Mack is the 10 percent owner of Viveve Medical Inc. Other key executives at Viveve Medical Inc include 10 percent owner Goldman Sachs Group Inc , 10 percent owner Goldman Sachs & Co. Llc , and 10 percent owner Wilmot B. Harkey .

Viveve Medical Inc (VIVE) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Viveve Medical Inc (VIVE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Viveve Medical Inc (VIVE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Viveve Medical Inc (VIVE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viveve Medical Inc Insider Transactions

No Available Data

What does Aytu BioPharma Inc do?

Who are the key executives at Aytu BioPharma Inc?

Daniel Mack is the 10 percent owner of Aytu BioPharma Inc. Other key executives at Aytu BioPharma Inc include Chief Financial Officer Mark K Oki , Chief Operating Officer Christopher Brooke , and Chief Business Officer Jarrett Disbrow .

Aytu BioPharma Inc (AYTU) Insider Trades Summary

Over the past 18 months, Daniel Mack made no insider transaction in Aytu BioPharma Inc (AYTU). Other recent insider transactions involving Aytu BioPharma Inc (AYTU) include a net purchase of 348,371 shares made by Joshua R. Disbrow , a net purchase of 100,000 shares made by Greg Pyszczymuka , and a net purchase of 90,000 shares made by Mark K Oki .

In summary, during the past 3 months, insiders sold 0 shares of Aytu BioPharma Inc (AYTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aytu BioPharma Inc (AYTU) were sold and 40,219 shares were bought by its insiders, resulting in a net purchase of 40,219 shares.

Aytu BioPharma Inc (AYTU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aytu BioPharma Inc Insider Transactions

No Available Data

Daniel Mack Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel Mack. You might contact Daniel Mack via mailing address: C/o Nantahala Capital Management, Llc, 130 Main St. 2nd Floor, New Canaan Ct 06840.

Discussions on Daniel Mack

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.